Publications by authors named "Zsolt Talloczy"

Claim this Profile
I
Inclisiran administration potently and durably lowers LDL-C over an extended-term follow-up: the ORION-8 trial.
R Scott Wright, Frederick J Raal, Wolfgang Koenig, Ulf Landmesser, Lawrence A Leiter, Zsolt Talloczy

Cardiovasc Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, Safety, and Tolerability of Inclisiran in Patients With Homozygous Familial Hypercholesterolemia: Results From the ORION-5 Randomized Clinical Trial.
Frederick Raal, Ronen Durst, Ran Bi, Zsolt Talloczy, Pierre Maheux

Circulation· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial.
Kausik K Ray, Roel P T Troquay, Frank L J Visseren, Lawrence A Leiter, R Scott Wright, Zsolt Talloczy

Lancet Diabetes Endocrinol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonsteroidal anti-inflammatory drug-sparing effect of secukinumab in patients with radiographic axial spondyloarthritis: 4-year results from the MEASURE 2, 3 and 4 phase III trials.
Maxime Dougados, Uta Kiltz, Alan Kivitz, Karel Pavelka, Susanne Rohrer, Zsolt Talloczy

Rheumatol Int· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secukinumab Demonstrates Sustained Efficacy and Safety in a Taiwanese Subpopulation With Active Ankylosing Spondylitis: Four-Year Results From a Phase 3 Study, MEASURE 1.
Jui-Cheng Tseng, James Cheng-Chung Wei, Atul Deodhar, Ruvie Martin, Brian Porter, Zsolt Talloczy

Front Immunol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of secukinumab 150 mg in ankylosing spondylitis: 5-year results from the phase III MEASURE 1 extension study.
Xenofon Baraliakos, Juergen Braun, Atul Deodhar, Denis Poddubnyy, Alan Kivitz, Zsolt Talloczy

RMD Open· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 study.
Jürgen Braun, Xenofon Baraliakos, Atul Deodhar, Denis Poddubnyy, Paul Emery, Zsolt Talloczy

Rheumatology (Oxford)· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Secukinumab 150 mg with and Without Loading Regimen in Ankylosing Spondylitis: 104-week Results from MEASURE 4 Study.
Alan J Kivitz, Ulf Wagner, Eva Dokoupilova, Jerzy Supronik, Ruvie Martin, Zsolt Talloczy

Rheumatol Ther· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effects of interleukin-17A inhibition with secukinumab in active ankylosing spondylitis: 3-year efficacy and safety results from an extension of the Phase 3 MEASURE 1 trial.
Xenofon Baraliakos, Alan J Kivitz, Atul A Deodhar, Jürgen Braun, James C Wei, Zsolt Talloczy

Clin Exp Rheumatol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Akt suppresses retrograde degeneration of dopaminergic axons by inhibition of macroautophagy.
Hsiao-Chun Cheng, Sang Ryong Kim, Tinmarla F Oo, Tatyana Kareva, Olga Yarygina, Zsolt Talloczy

J Neurosci· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease.
Marta Martinez-Vicente, Zsolt Talloczy, Esther Wong, Guomei Tang, Hiroshi Koga

Nat Neurosci· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autophagy protects against Sindbis virus infection of the central nervous system.
Anthony Orvedahl, Sarah MacPherson, Rhea Sumpter, Zsolt Tallóczy, Zhongju Zou

Cell Host Microbe· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuronal pigmented autophagic vacuoles: lipofuscin, neuromelanin, and ceroid as macroautophagic responses during aging and disease.
David Sulzer, Eugene Mosharov, Zsolt Talloczy, Fabio A Zucca, John D Simon

J Neurochem· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive autophagy in Alexander disease-affected astrocytes.
Guomei Tang, Zhenyu Yue, Zsolt Talloczy, James E Goldman

Autophagy· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive autophagy in Alexander disease-affected astrocytes.
Guomei Tang, Zhenyu Yue, Zsolt Tallóczy, James E Goldman

Autophagy· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autophagy induced by Alexander disease-mutant GFAP accumulation is regulated by p38/MAPK and mTOR signaling pathways.
Guomei Tang, Zhenyu Yue, Zsolt Talloczy, Tracy Hagemann, Woosung Cho

Hum Mol Genet· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy.
Marta Martinez-Vicente, Zsolt Talloczy, Susmita Kaushik, Ashish C Massey, Joseph Mazzulli

J Clin Invest· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes.
Daniel J Klionsky, Hagai Abeliovich, Patrizia Agostinis, Devendra K Agrawal, Gjumrakch Aliev

Autophagy· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methamphetamine inhibits antigen processing, presentation, and phagocytosis.
Zsolt Tallóczy, Jose Martinez, Danielle Joset, Yonaton Ray, Attila Gácser

PLoS Pathog· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HSV-1 ICP34.5 confers neurovirulence by targeting the Beclin 1 autophagy protein.
Anthony Orvedahl, Diane Alexander, Zsolt Tallóczy, Qihua Sun, Yongjie Wei

Cell Host Microbe· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PKR-dependent autophagic degradation of herpes simplex virus type 1.
Zsolt Tallóczy, Herbert W Virgin, Beth Levine

Autophagy· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autophagy regulates programmed cell death during the plant innate immune response.
Yule Liu, Michael Schiff, Kirk Czymmek, Zsolt Tallóczy, Beth Levine

Cell· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autophagy genes are essential for dauer development and life-span extension in C. elegans.
Alicia Meléndez, Zsolt Tallóczy, Matthew Seaman, Eeva-Liisa Eskelinen, David H Hall

Science· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of starvation- and virus-induced autophagy by the eIF2alpha kinase signaling pathway.
Zsolt Tallóczy, Wenxia Jiang, Herbert W Virgin, David A Leib, Donalyn Scheuner

Proc Natl Acad Sci U S A· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis